Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1537 - 1544 of 12089 results

An Overview of Shotgun Pleadings in the Federal Courts
August 7, 2023| Blog| Viewpoint

Tips For Employers Providing Employment Statements To Employees
August 7, 2023| News

The National AI Research Resource and the CREATE AI Act — AI: The Washington Report
August 4, 2023| Blog| Viewpoint

SEC Tells Broker-Dealers To Tighten Their Anti-Money Laundering Programs
August 4, 2023| News

A Template for Mandatory Employment Statements in Canada
August 3, 2023| Blog| Viewpoint

CMS Announces GUIDE – a New Dementia Care Model Designed for Participation by a Range of Providers
August 2, 2023| Blog| Viewpoint

Energy & Sustainability Washington Update — August 2023
August 2, 2023| Blog| Viewpoint

Federal Energy Regulatory Commission Issues Landmark Order to Improve Generator Interconnection Processes Across the US
August 2, 2023| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
